Navigation Links
Plexus Systems, Inc. Announces Participation at AM EXPO
Date:3/14/2008

Plexus Online to be featured at South's Leading Event for Advanced

Manufacturing

AUBURN HILLS, Mich., March 14 /PRNewswire/ -- Plexus Systems, Inc., provider of Plexus Online on-demand software for the manufacturing enterprise, announced it will participate at AM EXPO, the Advanced Manufacturing Exposition and Conference in Charlotte, North Carolina on March 19-20.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070627/CLW071LOGO )

This respected conference presents an opportunity to educate the world's leading suppliers and manufacturers about the virtues of Plexus Online SaaS modules and the benefits they bring to all facets of the enterprise. Plexus Online modules are specifically designed to improve production in precision manufacturing industries, such as medical devices, aerospace, food processing and automotive.

"We're eager to participate at AM EXPO and educate world class manufacturers about Plexus Online," said Mark Symonds, Chief Executive Officer for Plexus Systems, Inc. "Customers are constantly seeking an edge to help enhance manufacturing efficiency and profitability -- areas where we consistently bring superior results on behalf of our clients."

Plexus Online offers over 350 functional modules, providing manufacturers instant access to vital information and management functions using a simple Web browser. The on-demand solution features enterprise resource planning (ERP) functions such as accounting and finance modules, customer relationship management (CRM) features such as order entry and tracking, manufacturing execution systems (MES) functions such as production scheduling and machine integration and supply chain management (SCM) functions such as supplier quality and traceability.

About Plexus Systems, Inc.

Since 1995, Plexus Systems, Inc. (Auburn Hills, Mich.) has maintained a
'/>"/>

SOURCE Plexus Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
2. Plexus Systems, Inc. Names Khanna to Senior Account Manager - Western Region
3. Plexus Systems, Inc. Names Stosz to Solutions Engineer
4. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
5. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
6. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
7. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
8. FDA Grants Clearance to Langford IC Systems, Inc.
9. Four Rivers Software Systems, Inc. Announces the Promotion of Samantha Rouse to Senior Vice President of Product and Services
10. CAS Medical Systems, Inc. Ranked Among Connecticuts Fastest Growing Technology Companies
11. StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2Testosterone Therapy May Help Men With Heart Failure 55194 1Testosterone Therapy May Help Men With Heart Failure 55194 2Testosterone Therapy May Help Men With Heart Failure 55194 3